Pharmacoeconomic study of rivaroxaban and acetylsalicylic acid combination use in patients with coronary artery disease and/or peripheral artery disease
Aim. Comparative assessment of the economic results of rivaroxaban/acetylsalicylic acid (ASA) combination and ASA monotherapy use in patients with coronary artery disease (CAD) and/or peripheral artery disease (PAD). Material and methods. Based on the results of a large international multicenter, pl...
| Main Authors: | , , , , |
|---|---|
| 格式: | 文件 |
| 语言: | Russian |
| 出版: |
«FIRMA «SILICEA» LLC
2019-12-01
|
| 丛编: | Российский кардиологический журнал |
| 主题: | |
| 在线阅读: | https://russjcardiol.elpub.ru/jour/article/view/3584 |